English

BENITEC BIOPHARMA INC.

EDGAR

BNTC Current report (8-K) · filed 2026-10-28

41 filing records in this dataset, filed from 2020-08-14 to 2026-10-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-4.5 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -11600000 USD Source
Operating Cash Flow: -7100000 USD Source

Free cash flow

-4.52 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -11600000 USD Source
Operating Cash Flow: -7100000 USD Source
Capital Expenditure: 26000 USD Source
Capital Expenditure: 11000 USD Source

Cash and cash equivalents: 180 million USD 2026-06-30 Source
Exact value

180000000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 34.4 million shares 2026-06-30 Source
Exact value

34416834 shares

Reported share-count change

31.11% · 8.17 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

26250469 shares · 2025-06-30· Source
34416834 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-45.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -8965000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -11837000 USD · 2025-10-01 – 2025-12-31 Source
Net income: -11935000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -45546000 USD · 2025-07-01 – 2026-06-30 Source
Net income: -32737000 USD · 2025-07-01 – 2026-03-31 Source

Operating cash flow

-16.5 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -3400000 USD · 2025-07-01 – 2025-09-30 Source
Operating cash flow: -7100000 USD · 2025-07-01 – 2025-12-31 Source
Operating cash flow: -3400000 USD · 2025-07-01 – 2025-09-30 Source
Operating cash flow: -11600000 USD · 2025-07-01 – 2026-03-31 Source
Operating cash flow: -7100000 USD · 2025-07-01 – 2025-12-31 Source
Operating cash flow: -16500000 USD · 2025-07-01 – 2026-06-30 Source
Operating cash flow: -11600000 USD · 2025-07-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-28.

Financial data available through: 2026-06-30.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2021-06-30
Operating income: 8 of 11 periods available· newest 2026-06-30
Net income: 8 of 11 periods available· newest 2026-06-30
Operating cash flow: 8 of 11 periods available· newest 2026-06-30
Capital expenditure: 8 of 11 periods available· newest 2026-06-30
Total assets: 8 of 11 periods available· newest 2026-06-30
Total liabilities: 8 of 11 periods available· newest 2026-06-30
Current assets: 8 of 11 periods available· newest 2026-06-30
Current liabilities: 8 of 11 periods available· newest 2026-06-30
Cash and cash equivalents: 8 of 11 periods available· newest 2026-06-30
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2026-06-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 7.63 million

Prior period

−USD 37.92 million

2024-07-01 – 2025-06-30
Current period

−USD 45.55 million

2025-07-01 – 2026-06-30

Exact inputs and evidence

-45546000 − -37917000 = -7629000 USD

-37917000 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source
-45546000 USD · 2025-07-01 – 2026-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Year-over-year change in Net income: -7629000 USD Concept: fundies:NetIncome Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -45546000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#2461283 Filing: 000119312526390570 Input fundies:NetIncome: -37917000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#2463296 Filing: 000119312526390570
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 7.1 million

Prior period

−USD 23.6 million

2024-07-01 – 2025-06-30
Current period

−USD 16.5 million

2025-07-01 – 2026-06-30

Exact inputs and evidence

-16500000 − -23600000 = 7100000 USD

-23600000 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source
-16500000 USD · 2025-07-01 – 2026-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Year-over-year change in Operating cash flow: 7100000 USD Concept: fundies:OperatingCashFlow Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -16500000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1784828 Filing: 000119312526390570 Input fundies:OperatingCashFlow: -23600000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1785759 Filing: 000119312526390570
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+483.3%

Prior period

USD 18,000

2024-07-01 – 2025-06-30
Current period

USD 105,000

2025-07-01 – 2026-06-30

Exact inputs and evidence

105000 − 18000 = 87000 USD

18000 USD · 2024-07-01 – 2025-06-30
Inspect prior input Prior source
105000 USD · 2025-07-01 – 2026-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Year-over-year change in Capital expenditure: 87000 USD Concept: fundies:CapitalExpenditure Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 105000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1600790 Filing: 000119312526390570 Input fundies:CapitalExpenditure: 18000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1602789 Filing: 000119312526390570
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2020-07-01 – 2021-06-30

Revenue USD 59,000 100% of revenue
Operating costs Derived USD 13.66 million 23,144% of revenue
Operating income −USD 13.6 million −23,044% of revenue
Tax, interest and other Derived USD 286,000 485% of revenue
Net income −USD 13.88 million −23,529% of revenue

Cash

Operating cash flow −USD 12.8 million −21,695% of revenue
Capital expenditure USD 221,000 375% of revenue
Free cash flow Derived −USD 13.02 million −22,069% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Net income was higher than operating income, so the split is not drawn.
2020 Operating loss: operating costs were 8,219% of revenue.
2021 Operating loss: operating costs were 23,144% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2018-07-01 – 2019-06-30	12199000	9616000 Derived	2583000	-26000 Derived	2609000	4386000 Derived	Source 2018-07-01 – 2019-06-30: 12199000 USD Inspect Revenue Open source 2018-07-01 – 2019-06-30: 2583000 USD Inspect Operating Income Open source 2018-07-01 – 2019-06-30: 2609000 USD Inspect Net Income Open source 2018-07-01 – 2019-06-30: 4790000 USD Inspect Operating Cash Flow Open source 2018-07-01 – 2019-06-30: 404000 USD Inspect Capital Expenditure Open source
2020 2019-07-01 – 2020-06-30	102000	8383000 Derived	-8281000	-7000 Derived	-8274000	-7595000 Derived	Source 2019-07-01 – 2020-06-30: 102000 USD Inspect Revenue Open source 2019-07-01 – 2020-06-30: -8281000 USD Inspect Operating Income Open source 2019-07-01 – 2020-06-30: -8274000 USD Inspect Net Income Open source 2019-07-01 – 2020-06-30: -7500000 USD Inspect Operating Cash Flow Open source 2019-07-01 – 2020-06-30: 95000 USD Inspect Capital Expenditure Open source
2021 2020-07-01 – 2021-06-30	59000	13655000 Derived	-13596000	286000 Derived	-13882000	-13021000 Derived	Source 2020-07-01 – 2021-06-30: 59000 USD Inspect Revenue Open source 2020-07-01 – 2021-06-30: -13596000 USD Inspect Operating Income Open source 2020-07-01 – 2021-06-30: -13882000 USD Inspect Net Income Open source 2020-07-01 – 2021-06-30: -12800000 USD Inspect Operating Cash Flow Open source 2020-07-01 – 2021-06-30: 221000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 59K 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-06-30	Revenue	12199000	Revenue: 12199000 Open source
20202020-06-30	Revenue	102000	Revenue: 102000 Open source
20212021-06-30	Revenue	59000	Revenue: 59000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-42.2% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Year over year	No prior comparable period	Revenue: 12199000 Open source
20202020-06-30	Year over year	-99.2%	Revenue: 102000 Open source Revenue: 12199000 Open source
20212021-06-30	Year over year	-42.2%	Revenue: 59000 Open source Revenue: 102000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -23,044.1% 2021

Net margin -23,528.8% 2021

Free cash flow margin -22,069.5% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Operating margin	21.2%	Operating Income: 2583000 Open source Revenue: 12199000 Open source
20202020-06-30	Operating margin	-8,118.6%	Operating Income: -8281000 Open source Revenue: 102000 Open source
20212021-06-30	Operating margin	-23,044.1%	Operating Income: -13596000 Open source Revenue: 59000 Open source
20192019-06-30	Net margin	21.4%	Net Income: 2609000 Open source Revenue: 12199000 Open source
20202020-06-30	Net margin	-8,111.8%	Net Income: -8274000 Open source Revenue: 102000 Open source
20212021-06-30	Net margin	-23,528.8%	Net Income: -13882000 Open source Revenue: 59000 Open source
20192019-06-30	Free cash flow margin	36%	Revenue: 12199000 Open source Operating Cash Flow: 4790000 Open source Capital Expenditure: 404000 Open source
20202020-06-30	Free cash flow margin	-7,446.1%	Revenue: 102000 Open source Operating Cash Flow: -7500000 Open source Capital Expenditure: 95000 Open source
20212021-06-30	Free cash flow margin	-22,069.5%	Revenue: 59000 Open source Operating Cash Flow: -12800000 Open source Capital Expenditure: 221000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -12.8M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-06-30	Operating cash flow	4790000	Operating Cash Flow: 4790000 Open source
20202020-06-30	Operating cash flow	-7500000	Operating Cash Flow: -7500000 Open source
20212021-06-30	Operating cash flow	-12800000	Operating Cash Flow: -12800000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-06-30	Free cash flow	4386000	Operating Cash Flow: 4790000 Open source Capital Expenditure: 404000 Open source
20202020-06-30	Free cash flow	-7595000	Operating Cash Flow: -7500000 Open source Capital Expenditure: 95000 Open source
20212021-06-30	Free cash flow	-13021000	Operating Cash Flow: -12800000 Open source Capital Expenditure: 221000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

6.4% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Liabilities / assets	13.7%	Total Liabilities: 2641000 Open source Total Assets: 19235000 Open source
20202020-06-30	Liabilities / assets	11.6%	Total Liabilities: 1349000 Open source Total Assets: 11587000 Open source
20212021-06-30	Liabilities / assets	6.4%	Total Liabilities: 1369000 Open source Total Assets: 21379000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

15.05× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20192019-06-30	Current assets / current liabilities	7.1×	Current Assets: 18756000 Open source Current Liabilities: 2641000 Open source
20202020-06-30	Current assets / current liabilities	9.51×	Current Assets: 10809000 Open source Current Liabilities: 1136000 Open source
20212021-06-30	Current assets / current liabilities	15.05×	Current Assets: 20608000 Open source Current Liabilities: 1369000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2018-07-01 – 2019-06-30	USD 2.61 million Exact value Exact value: 2609000 USD 2018-07-01 – 2019-06-30: 2609000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2019-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: 2609000 USD Concept: fundies:NetIncome Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:NetIncome: 2609000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312520252381/bntc-20200630.xml#75753 Filing: 000119312520252381 The citation records this snapshot. The page link may show a newer release later.	USD 4.79 million Exact value Exact value: 4790000 USD 2018-07-01 – 2019-06-30: 4790000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2019-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: 4790000 USD Concept: fundies:OperatingCashFlow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 4790000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312520252381/bntc-20200630.xml#80790 Filing: 000119312520252381 The citation records this snapshot. The page link may show a newer release later.	USD 404,000 Exact value Exact value: 404000 USD 2018-07-01 – 2019-06-30: 404000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2019-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 404000 USD Concept: fundies:CapitalExpenditure Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 404000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312520252381/bntc-20200630.xml#81196 Filing: 000119312520252381 The citation records this snapshot. The page link may show a newer release later.	USD 4.39 million Calculation and evidence 4790000 − 404000 USD Exact free cash flow: 4386000 USD 2018-07-01 – 2019-06-30: 4790000 USD · Inspect Operating Cash Flow · Source 2018-07-01 – 2019-06-30: 404000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2019-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: 4386000 USD Concept: free-cash-flow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 4790000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312520252381/bntc-20200630.xml#80790 Filing: 000119312520252381 Input fundies:CapitalExpenditure: 404000 USD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312520252381/bntc-20200630.xml#81196 Filing: 000119312520252381 The citation records this snapshot. The page link may show a newer release later.
2020 2019-07-01 – 2020-06-30	−USD 8.27 million Exact value Exact value: -8274000 USD 2019-07-01 – 2020-06-30: -8274000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2020-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -8274000 USD Concept: fundies:NetIncome Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:NetIncome: -8274000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312521276758/d182332d10k.htm#1779035 Filing: 000119312521276758 The citation records this snapshot. The page link may show a newer release later.	−USD 7.5 million Exact value Exact value: -7500000 USD 2019-07-01 – 2020-06-30: -7500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2020-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -7500000 USD Concept: fundies:OperatingCashFlow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7500000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312521276758/d182332d10k.htm#1418066 Filing: 000119312521276758 The citation records this snapshot. The page link may show a newer release later.	USD 95,000 Exact value Exact value: 95000 USD 2019-07-01 – 2020-06-30: 95000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2020-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 95000 USD Concept: fundies:CapitalExpenditure Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 95000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312521276758/d182332d10k.htm#1290493 Filing: 000119312521276758 The citation records this snapshot. The page link may show a newer release later.	−USD 7.6 million Calculation and evidence -7500000 − 95000 USD Exact free cash flow: -7595000 USD 2019-07-01 – 2020-06-30: -7500000 USD · Inspect Operating Cash Flow · Source 2019-07-01 – 2020-06-30: 95000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2020-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -7595000 USD Concept: free-cash-flow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7500000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312521276758/d182332d10k.htm#1418066 Filing: 000119312521276758 Input fundies:CapitalExpenditure: 95000 USD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312521276758/d182332d10k.htm#1290493 Filing: 000119312521276758 The citation records this snapshot. The page link may show a newer release later.
2021 2020-07-01 – 2021-06-30	−USD 13.88 million Exact value Exact value: -13882000 USD 2020-07-01 – 2021-06-30: -13882000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2021-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -13882000 USD Concept: fundies:NetIncome Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:NetIncome: -13882000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312522237075/d360350d10k.htm#1493458 Filing: 000119312522237075 The citation records this snapshot. The page link may show a newer release later.	−USD 12.8 million Exact value Exact value: -12800000 USD 2020-07-01 – 2021-06-30: -12800000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2021-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -12800000 USD Concept: fundies:OperatingCashFlow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12800000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312522237075/d360350d10k.htm#1241297 Filing: 000119312522237075 The citation records this snapshot. The page link may show a newer release later.	USD 221,000 Exact value Exact value: 221000 USD 2020-07-01 – 2021-06-30: 221000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2021-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 221000 USD Concept: fundies:CapitalExpenditure Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 221000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312522237075/d360350d10k.htm#1129253 Filing: 000119312522237075 The citation records this snapshot. The page link may show a newer release later.	−USD 13.02 million Calculation and evidence -12800000 − 221000 USD Exact free cash flow: -13021000 USD 2020-07-01 – 2021-06-30: -12800000 USD · Inspect Operating Cash Flow · Source 2020-07-01 – 2021-06-30: 221000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2021-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -13021000 USD Concept: free-cash-flow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12800000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312522237075/d360350d10k.htm#1241297 Filing: 000119312522237075 Input fundies:CapitalExpenditure: 221000 USD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312522237075/d360350d10k.htm#1129253 Filing: 000119312522237075 The citation records this snapshot. The page link may show a newer release later.
2022 2021-07-01 – 2022-06-30	−USD 18.21 million Exact value Exact value: -18208000 USD 2021-07-01 – 2022-06-30: -18208000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2022-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -18208000 USD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:NetIncome: -18208000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312523239121/d549728d10k.htm#1302310 Filing: 000119312523239121 The citation records this snapshot. The page link may show a newer release later.	−USD 15.9 million Exact value Exact value: -15900000 USD 2021-07-01 – 2022-06-30: -15900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2022-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -15900000 USD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15900000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312523239121/d549728d10k.htm#1058124 Filing: 000119312523239121 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 2021-07-01 – 2022-06-30: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2022-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312523239121/d549728d10k.htm#952833 Filing: 000119312523239121 The citation records this snapshot. The page link may show a newer release later.	−USD 15.91 million Calculation and evidence -15900000 − 13000 USD Exact free cash flow: -15913000 USD 2021-07-01 – 2022-06-30: -15900000 USD · Inspect Operating Cash Flow · Source 2021-07-01 – 2022-06-30: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2022-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -15913000 USD Concept: free-cash-flow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -15900000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312523239121/d549728d10k.htm#1058124 Filing: 000119312523239121 Input fundies:CapitalExpenditure: 13000 USD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312523239121/d549728d10k.htm#952833 Filing: 000119312523239121 The citation records this snapshot. The page link may show a newer release later.
2023 2022-07-01 – 2023-06-30	−USD 19.56 million Exact value Exact value: -19562000 USD 2022-07-01 – 2023-06-30: -19562000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2023-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -19562000 USD Concept: fundies:NetIncome Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=USD&dimensions= Input fundies:NetIncome: -19562000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/d640181d10k.htm#1414044 Filing: 000119312524226968 The citation records this snapshot. The page link may show a newer release later.	−USD 18 million Exact value Exact value: -18000000 USD 2022-07-01 – 2023-06-30: -18000000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2023-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -18000000 USD Concept: fundies:OperatingCashFlow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -18000000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/d640181d10k.htm#1129765 Filing: 000119312524226968 The citation records this snapshot. The page link may show a newer release later.	USD 1,000 Exact value Exact value: 1000 USD 2022-07-01 – 2023-06-30: 1000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2023-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 1000 USD Concept: fundies:CapitalExpenditure Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/d640181d10k.htm#1014064 Filing: 000119312524226968 The citation records this snapshot. The page link may show a newer release later.	−USD 18 million Calculation and evidence -18000000 − 1000 USD Exact free cash flow: -18001000 USD 2022-07-01 – 2023-06-30: -18000000 USD · Inspect Operating Cash Flow · Source 2022-07-01 – 2023-06-30: 1000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2023-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -18001000 USD Concept: free-cash-flow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -18000000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/d640181d10k.htm#1129765 Filing: 000119312524226968 Input fundies:CapitalExpenditure: 1000 USD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312524226968/d640181d10k.htm#1014064 Filing: 000119312524226968 The citation records this snapshot. The page link may show a newer release later.
2024 2023-07-01 – 2024-06-30	−USD 21.75 million Exact value Exact value: -21751000 USD 2023-07-01 – 2024-06-30: -21751000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2024-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -21751000 USD Concept: fundies:NetIncome Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=USD&dimensions= Input fundies:NetIncome: -21751000 USD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/d226768d10ka.htm#1741550 Filing: 000119312526117604 The citation records this snapshot. The page link may show a newer release later.	−USD 19.4 million Exact value Exact value: -19400000 USD 2023-07-01 – 2024-06-30: -19400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2024-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -19400000 USD Concept: fundies:OperatingCashFlow Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19400000 USD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/d226768d10ka.htm#1342310 Filing: 000119312526117604 The citation records this snapshot. The page link may show a newer release later.	USD 179,000 Exact value Exact value: 179000 USD 2023-07-01 – 2024-06-30: 179000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2024-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 179000 USD Concept: fundies:CapitalExpenditure Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 179000 USD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/d226768d10ka.htm#396998 Filing: 000119312526117604 The citation records this snapshot. The page link may show a newer release later.	−USD 19.58 million Calculation and evidence -19400000 − 179000 USD Exact free cash flow: -19579000 USD 2023-07-01 – 2024-06-30: -19400000 USD · Inspect Operating Cash Flow · Source 2023-07-01 – 2024-06-30: 179000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2024-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -19579000 USD Concept: free-cash-flow Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19400000 USD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/d226768d10ka.htm#1342310 Filing: 000119312526117604 Input fundies:CapitalExpenditure: 179000 USD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/d226768d10ka.htm#396998 Filing: 000119312526117604 The citation records this snapshot. The page link may show a newer release later.
2025 2024-07-01 – 2025-06-30	−USD 37.92 million Exact value Exact value: -37917000 USD 2024-07-01 – 2025-06-30: -37917000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2025-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -37917000 USD Concept: fundies:NetIncome Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=USD&dimensions= Input fundies:NetIncome: -37917000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#2463296 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.	−USD 23.6 million Exact value Exact value: -23600000 USD 2024-07-01 – 2025-06-30: -23600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2025-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -23600000 USD Concept: fundies:OperatingCashFlow Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23600000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1785759 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.	USD 18,000 Exact value Exact value: 18000 USD 2024-07-01 – 2025-06-30: 18000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2025-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 18000 USD Concept: fundies:CapitalExpenditure Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1602789 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.	−USD 23.62 million Calculation and evidence -23600000 − 18000 USD Exact free cash flow: -23618000 USD 2024-07-01 – 2025-06-30: -23600000 USD · Inspect Operating Cash Flow · Source 2024-07-01 – 2025-06-30: 18000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2025-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -23618000 USD Concept: free-cash-flow Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23600000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1785759 Filing: 000119312526390570 Input fundies:CapitalExpenditure: 18000 USD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1602789 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.
2026 2025-07-01 – 2026-06-30	−USD 45.55 million Exact value Exact value: -45546000 USD 2025-07-01 – 2026-06-30: -45546000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Net Income: -45546000 USD Concept: fundies:NetIncome Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ANetIncome&period=2026-06-30&surface=latest&period_type=duration&start=2025-07-01&unit=USD&dimensions= Input fundies:NetIncome: -45546000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#2461283 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.	−USD 16.5 million Exact value Exact value: -16500000 USD 2025-07-01 – 2026-06-30: -16500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Operating Cash Flow: -16500000 USD Concept: fundies:OperatingCashFlow Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3AOperatingCashFlow&period=2026-06-30&surface=latest&period_type=duration&start=2025-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16500000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1784828 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.	USD 105,000 Exact value Exact value: 105000 USD 2025-07-01 – 2026-06-30: 105000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Capital Expenditure: 105000 USD Concept: fundies:CapitalExpenditure Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898/explain?concept=fundies%3ACapitalExpenditure&period=2026-06-30&surface=latest&period_type=duration&start=2025-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 105000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1600790 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.	−USD 16.61 million Calculation and evidence -16500000 − 105000 USD Exact free cash flow: -16605000 USD 2025-07-01 – 2026-06-30: -16500000 USD · Inspect Operating Cash Flow · Source 2025-07-01 – 2026-06-30: 105000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BENITEC BIOPHARMA INC. · 2026-06-30 BENITEC BIOPHARMA INC. (edgar:1808898) Free cash flow: -16605000 USD Concept: free-cash-flow Period: 2025-07-01 to 2026-06-30 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1808898?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16500000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1784828 Filing: 000119312526390570 Input fundies:CapitalExpenditure: 105000 USD (2025-07-01 to 2026-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1808898/000119312526390570/bntc-20260630.htm#1600790 Filing: 000119312526390570 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

41 filings · 1,553 latest values · 1,553 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001808898, 1808898, BNTC, edgar:1808898

Also known as BENITEC BIOPHARMA INC., Benitec Biopharma Inc., Benitec Biopharma Inc.

BENITEC BIOPHARMA INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2021 2020-07-01 – 2021-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation